161416-57-5 Usage
Description
(S)-3-(PYRROLIDIN-2-YLMETHOXY)PYRIDINE, with the molecular formula C11H15NO and a molecular weight of 177.24 g/mol, is a heterocyclic compound characterized by the presence of both a pyridine and a pyrrolidine ring. These structural features confer unique properties to the compound, making it a valuable building block in the synthesis of pharmaceuticals and agrochemicals. It has been studied for its potential use in treating various medical conditions and may exhibit promising biological activities due to its distinctive structure.
Uses
Used in Pharmaceutical Industry:
(S)-3-(PYRROLIDIN-2-YLMETHOXY)PYRIDINE is used as a building block for the synthesis of pharmaceuticals, leveraging its unique structural features to contribute to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
Similarly, in the agrochemical industry, (S)-3-(PYRROLIDIN-2-YLMETHOXY)PYRIDINE serves as a key component in the creation of agrochemicals, potentially enhancing crop protection and yield through its incorporation into various formulations.
Used in Research and Development:
In the realm of research and development, (S)-3-(PYRROLIDIN-2-YLMETHOXY)PYRIDINE is utilized for exploring its potential biological activities and investigating its efficacy in treating a range of medical conditions, thereby contributing to the advancement of scientific knowledge and potential new treatment options.
Check Digit Verification of cas no
The CAS Registry Mumber 161416-57-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,1,4,1 and 6 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 161416-57:
(8*1)+(7*6)+(6*1)+(5*4)+(4*1)+(3*6)+(2*5)+(1*7)=115
115 % 10 = 5
So 161416-57-5 is a valid CAS Registry Number.
InChI:InChI=1/C10H14N2O/c1-3-9(12-6-1)8-13-10-4-2-5-11-7-10/h2,4-5,7,9,12H,1,3,6,8H2/t9-/m0/s1
161416-57-5Relevant articles and documents
N-benzylisatin sulfonamide analogues as potent caspase-3 inhibitors: Synthesis, in vitro activity, and molecular modeling studies
Chu, Wenhua,Zhang, Jun,Zeng, Chenbo,Rothfuss, Justin,Tu, Zhude,Chu, Yunxiang,Reichert, David E.,Welch, Michael J.,Mach, Robert H.
, p. 7637 - 7647 (2007/10/03)
A number of isatin sulfonamide analogues were prepared and their potencies for inhibiting caspase-1, -3, -6, -7, and -8 were evaluated in vitro. Several compounds displaying a nanomolar potency for inhibiting the executioner caspases, caspase-3 and caspas
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release
-
, (2008/06/13)
Novel heterocyclic ether compounds of the formula: STR1 wherein n, *, R1, R2, R3 and y are specifically defined, or pharmaceutically acceptable salts or prodrugs thereof, which are useful in selectively controlling neurotransmitter release; therapeutically-effective pharmaceutical compositions of these compounds; and use of said compositions to selectively control neurotransmitter release in mammals.
